X-74456451-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006517.5(SLC16A2):​c.430+34384A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.441 in 110,193 control chromosomes in the GnomAD database, including 8,597 homozygotes. There are 14,299 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 8597 hom., 14299 hem., cov: 22)

Consequence

SLC16A2
NM_006517.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.976

Publications

4 publications found
Variant links:
Genes affected
SLC16A2 (HGNC:10923): (solute carrier family 16 member 2) This gene encodes an integral membrane protein that functions as a transporter of thyroid hormone. The encoded protein facilitates the cellular importation of thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3) and diidothyronine (T2). This gene is expressed in many tissues and likely plays an important role in the development of the central nervous system. Loss of function mutations in this gene are associated with psychomotor retardation in males while females exhibit no neurological defects and more moderate thyroid-deficient phenotypes. This gene is subject to X-chromosome inactivation. Mutations in this gene are the cause of Allan-Herndon-Dudley syndrome. [provided by RefSeq, Mar 2012]
SLC16A2 Gene-Disease associations (from GenCC):
  • Allan-Herndon-Dudley syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.937 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006517.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC16A2
NM_006517.5
MANE Select
c.430+34384A>G
intron
N/ANP_006508.2P36021

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC16A2
ENST00000587091.6
TSL:1 MANE Select
c.430+34384A>G
intron
N/AENSP00000465734.1P36021
SLC16A2
ENST00000878592.1
c.430+34384A>G
intron
N/AENSP00000548651.1
SLC16A2
ENST00000922847.1
c.508+3618A>G
intron
N/AENSP00000592906.1

Frequencies

GnomAD3 genomes
AF:
0.441
AC:
48522
AN:
110144
Hom.:
8587
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.597
Gnomad AMI
AF:
0.212
Gnomad AMR
AF:
0.507
Gnomad ASJ
AF:
0.309
Gnomad EAS
AF:
0.965
Gnomad SAS
AF:
0.604
Gnomad FIN
AF:
0.351
Gnomad MID
AF:
0.372
Gnomad NFE
AF:
0.316
Gnomad OTH
AF:
0.428
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.441
AC:
48583
AN:
110193
Hom.:
8597
Cov.:
22
AF XY:
0.440
AC XY:
14299
AN XY:
32493
show subpopulations
African (AFR)
AF:
0.597
AC:
18052
AN:
30225
American (AMR)
AF:
0.507
AC:
5234
AN:
10317
Ashkenazi Jewish (ASJ)
AF:
0.309
AC:
812
AN:
2626
East Asian (EAS)
AF:
0.965
AC:
3342
AN:
3464
South Asian (SAS)
AF:
0.603
AC:
1551
AN:
2571
European-Finnish (FIN)
AF:
0.351
AC:
2031
AN:
5788
Middle Eastern (MID)
AF:
0.374
AC:
80
AN:
214
European-Non Finnish (NFE)
AF:
0.316
AC:
16674
AN:
52792
Other (OTH)
AF:
0.437
AC:
664
AN:
1521
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
879
1758
2636
3515
4394
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
466
932
1398
1864
2330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.380
Hom.:
12949
Bravo
AF:
0.464

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.29
DANN
Benign
0.62
PhyloP100
-0.98
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs496549; hg19: chrX-73676286; API